Parker Waichman LLP

Drug Resistant Superbugs Pose Urgent Threats, Report Says

Antibiotic misuse and overuse is a dangerous practice directly tied to antibiotic resistant diseases that wreak serious havoc on the body, increasing widespread drug resistance. Because antibiotic resistance has become so prevalent so rapidly, a lack of proper medication now exists The overuse and misuse of antibiotics provides an ideal environment that encourages harmful bacteria […]

drug_resistant_superbug_dangersAntibiotic misuse and overuse is a dangerous practice directly tied to antibiotic resistant diseases that wreak serious havoc on the body, increasing widespread drug resistance. Because antibiotic resistance has become so prevalent so rapidly, a lack of proper medication now exists

The overuse and misuse of antibiotics provides an ideal environment that encourages harmful bacteria to remain in the body, killing off good bacteria. In the meantime, the harmful bacteria grows increasingly more resistant to antibiotic treatments. This ongoing practice of overusing and misusing antibiotics has enabled, and continues to enable, bacteria to outsmart antibiotics and to survive, thrive, and strengthen so that existing antibiotic drugs are now becoming powerless against their eradication, creating serious, extensive antibiotic resistance.

Three urgent public health threats have just been identified in the United States, according to Reuters: Antibiotic-resistant gonorrhea; C. difficile, a diarrhea-causing superbug; and a class of rapidly growing killer bacteria—carbapenem-resistant Enterobacteriaceae (CRE)—called a “nightmare.”

A new U.S. Centers for Disease Control and Prevention (CDC) report reveals that every year, about 2 million Americans develop serious bacterial infections that are resistant to one or more antibiotics; at least 23,000 people die from infections each year. “For organism after organism, we’re seeing this steady increase in resistance rates,” Dr. Thomas Frieden, director of the CDC, told Reuters. “We don’t have new drugs about to come out of the pipeline. If and when we get new drugs, unless we do a better job of protecting them, we’ll lose those, also.”

There are not enough emerging that have been developed and released in the past few decades to counteract resistant germs and only a few drug makers are working on antibiotic drug development to replace current medications, according to Reuters. And, the problem is not limited to the U.S. Last March, England’s chief medical officer announced that antibiotic resistance poses a “catastrophic health threat” there following a World Health Organization (WHO) report revealing that a superbug gonorrhea strain had spread to several European countries.

The CDC report ranking for drug resistant superbug threats as urgent, severe, and concerning; rankings are based on health and economic impacts, the number of cases, the ease of transmission, and available and effective antibiotics, Reuters explained. CRE has been deemed urgent—Frieden described CRE as a “nightmare bacteria” that has no cure, even with the strongest antibiotics. CRE sickens 9,300 people annually and the two most common strains—carbapenem-resistant Klebsiella spp. and carbapenem-resistant E. coli—are tied to 600 deaths yearly. “For CRE, we’re seeing increases from 1 state to 38 states in the last decade,” Frieden told Reuters.

C. difficile causes life-threatening diarrhea and typically spreads via contaminated equipment, healthcare workers, and visitors. Because of widespread hospital antibiotic use, C. difficile has become especially virulent, killing good gut bacteria for months, and enabling C. difficile to thrive, Reuters explained. C. difficile leads to 250,000 infections and 14,000 deaths each year in the U.S., costing $1 billion in excess medical costs; fatalities increased 400 percent from 2000 to 2007, Reuters reported.

Drug-resistant Neisseria gonorrhoeae leads to 246,000 U.S. cases annually; gonorrhea is becoming resistant to tetracycline, cefixime, ceftriaxone, and azithromycin, which had long been the disease’s best treatments.

“The three organisms that have been chosen as urgent are all increasing at an alarming rate to which therapies are limited,” Dr. Edward Septimus, an infectious disease expert at HCA Healthcare System in Houston, Texas, and a member of the Infectious Diseases Society of America’s Antimicrobial Resistance Workgroup, told Reuters. Septimus noted that urgent and serious categories, which include Methicillin-resistant Staphylococcus aureus (MRSA) and drug-resistant tuberculosis, are “certainly worthy of immediate response. I do believe it’s a looming public-health crisis,” he added.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
They were thorough, courteous professional, compassionate and efficient every step of the way. I felt very competent and secure knowing they were handling my case.
louie m
a month ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value
michael dalton
2 years ago
5 Star Reviews 150
Michelle Josama was absolutely fantastic. Glad we got her for our case. Had a great experience!
Rafael Garcia
5 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038